Researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other for diagnosed patients who do not require a hospital stay.
Other News
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…
A study conducted by the UMN College of Veterinary Medicine found that household cats were more susceptible than dogs to natural infection…
As the first trial of its kind, researchers will use common and widely available drugs to treat symptoms of COVID-19. This story was…